OptimizeRx Corp’s recent filing unveils that its Director Lang James Paul acquired Company’s shares for reported $2.44 million on Mar 14 ’25. In the deal valued at $7.60 per share,321,408 shares were bought. As a result of this transaction, Lang James Paul now holds 389,452 shares worth roughly $6.01 million.
Then, FEBBO WILLIAM J bought 20,000 shares, generating $100,220 in total proceeds. Upon buying the shares at $5.01, the CEO now owns 601,253 shares.
RBC Capital Mkts downgraded its OptimizeRx Corp [OPRX] rating to a Sector perform from a an Outperform in a research note published on January 08, 2025; the price target was decreased to $6 from $7. A number of analysts have revised their coverage, including Stephens’s analysts, who began to cover the stock in mid December with a ‘”an Equal-weight”‘ rating. JMP Securities started covering the stock on April 04, 2024. It rated OPRX as “a Mkt outperform”.
Price Performance Review of OPRX
On Tuesday, OptimizeRx Corp [NASDAQ:OPRX] saw its stock jump 4.61% to $15.44. Over the last five days, the stock has gained 16.79%. OptimizeRx Corp shares have risen nearly 217.70% since the year began. Nevertheless, the stocks have risen 36.76% over the past one year.
How much short interest is there in OptimizeRx Corp?
A steep rise in short interest was recorded in OptimizeRx Corp stocks on 2025-05-30, dropping by -0.29 million shares to a total of 1.54 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 1.83 million shares. There was a decline of -18.58%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 03, 2024 when Barclays began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $15 price target.
